Taking Care of Our #Pets:
More #CBD Pet Products Coming to Market Drive Quality and Innovation (TSX: $WEED.TO)
(NYSE: $CGC) (OTC: $LRSV) (OTC: $MJNA) (TSXV: $EAST.V)
Point Roberts WA,
Delta BC – April 29, 2019 - Investorideas.com, a leading investor
news resource covering hemp and cannabis stocks releases a snapshot looking at
how as the CBD pet market grows, more companies are putting in extra effort to
create quality products and innovative technologies to ensure the best care possible
for pets that are often considered family members by consumers.
Read this in full at https://www.investorideas.com/news/2019/cannabis/04292Stocks-CBDPetProducts.asp
A recent study published in The Pet
Behavior Science Journal indicates that dogs with epilepsy can have less
frequent seizures if treated using CBD oil.
While the study may
have been small because it only followed three dogs over a period of two months
while those dogs were treated with CBD oil, the research suggests that dogs
respond to cannabis treatment in the same way that humans do.
One of the largest
cannabis companies in the world, Canopy
Growth Corporation (TSX:WEED) (NYSE:CGC) and Sequential Brands Group, Inc. announced back in February
that Martha Stewart had joined the Company in an advisory role to assist with
developing and positioning a broad new line of product offerings across
multiple categories, with a focus on pet products.
“I am delighted to
establish this partnership with Canopy Growth and share with them the knowledge
I have gained after years of experience in the subject of living,” said Martha
Stewart. “I’m especially looking forward to our first collaboration together,
which will offer sensible products for people’s beloved pets.”
While we are still
waiting with baited breath for more news and developments on Canopy’s pet
product line, the company is not sitting idly by and is ensuring proper supply
arrangements so as to be prepared to enter the market. More recently, the company announced its acquisition of
AgriNextUSA, a hemp enterprise led by CEO Geoff Whaling, which has been at the
forefront of hemp advocacy and building a vibrant hemp sector in the US. The
acquisition will accelerate Canopy Growth’s entry into key American
jurisdictions as regulations surrounding the full use of hemp as a crop begin
to be implemented, thanks in part to the recently enacted 2018 US Farm Bill.
Hemp has the
potential to disrupt several prominent industries: advanced materials,
cosmetics, energy, fiber and textiles, food and protein production and the
health and wellness sectors. In addition, hemp is a natural source of CBD, the
non-intoxicating component of cannabis that can be used for health and wellness
purposes, as well as pet products in jurisdictions where legally permitted.
LinkResPet, a
subsidiary of Link Reservations Inc.
(OTC: LRSV), a
company providing CBD products especially tailored for pets, has recently announced that
it is finalizing negotiations with a certified US-based CBD producer and
fulfillment center and are currently in the final stage of negotiations.
Link
Reservations Inc. is looking to establish itself in the US/North American
market and has been communicating with various producers in order to find
partners that meet their high standards, and has now found such a producer to
advance on their first partnership.
Upon
this arrangement being successfully completed and as the company explores
retail opportunities, LRSV will be able to offer home delivery of its CBD pet
products in the US and Canada. The company will also be in a position to supply
products to brick & mortar pet retailers. This will be a key for future
growth as the LinkResPet product line increases.
René
Lauritsen, Link Reservations Inc. CEO commented: “This is a huge step for LRSV
and our brand LinkResPet, and we are incredibly excited to be making advances
in North America. We selected our new partner due to their high-grade CBD
products and flexibility in production and delivery timeframes. We ensure our
products undergo a rigorous process of quality control and testing, using the
latest scientific methods that will confirm their quality and safety, which of
course includes being free of bacteria, pesticides, mold, solvents, and other
contaminants."
The
producer is specialized in “SFE” technique (Supercritical Fluid Extraction),
using state of the art equipment. “SFE/CO2 Extraction” is the most
sophisticated method of professionally producing hemp oil extract, gently
obtaining the extract and preserving many of the plant’s active molecules,
while being environmentally friendly and sustainable. In this process,
supercritical CO2 (carbon dioxide) gas is used in natural product extraction,
offering the possibility to separate materials from each other selectively and
with great care.
Medical Marijuana, Inc. (OTC: MJNA), the
first-ever publicly traded cannabis company in the United States’ subsidiary, Phyto Animal Health recently announced the launch of
its newest CBD pet product, HempBone Smoked Salmon Bites for cats.
HempBone
Smoked Salmon Bites are artisanal star-shaped cat treats that are soft-baked
and naturally-flavored to taste like smoked salmon and roasted seafood.
Small
cats can enjoy three to four bites daily to help support overall wellness,
while larger cats may require a larger serving. CBD has been studied
extensively by top-veterinarians to promote cardiovascular function, support
healthy joints, and promote neurological health and emotional behavior in pets.
"Our
HempBone Bacon Apple Donuts have gained incredible popularity over the past
year because of their natural allergen-free ingredients and palatable taste
that dogs love," said Phyto Animal Health CEO, Ian Quinn. "We wanted
to offer a safe and nutritious snack for cats as well so we created HempBone
Smoked Salmon Bites. They are one-fourth of the CBD per serving size as the
Bacon Apple Donuts and feature a more feline-focused flavor, better meeting the
dosing needs and taste preferences of cats."
"There
is currently an upward trend in the CBD pet supplement industry and for good
reason," said Medical Marijuana, Inc. CEO, Dr. Stuart Titus. "Phyto
Animal Health leads this industry trend with premium quality,
veterinarian-recommended CBD supplements in a variety of options that are
customized to meet the needs of pets of many different sizes and species."
EastWest
Bioscience Inc. (TSX-V: EAST) is also bringing new innovative products to market,
having announced four additional products to its
Natural Pet Science line, both in Canada and the US, with CBD included in the
US destined products which will be marketed to CBD permitted jurisdictions.
Overshadowed by the significance of the CBD opportunity
that the signing of the 2018 Farm Bill presented, in December 2018, The US Food
and Drug Administration completed its evaluation of three generally recognized
as safe (GRAS) notices for hemp seed-derived food ingredients. These
ingredients being hulled hemp seed (GRN765), hemp seed protein powder (GRN771)
and hemp seed oil (GRN778). These notices represent a real market opportunity
for EastWest, which validates the Company's Canadian ‘product first' strategy.
EastWest's product development and sales strategy in the
US will be similar to what it used to grow retail shelf space in Canada. Now
that there is FDA approval for hemp-based foods, the Company's interesting and
innovative hemp-based products with unique formulations and ingredients become
attractive to distributors. As Eastwest's hemp products become established in
retail stores and distribution networks it lowers the barrier of entry for the
Company's CBD infused products.
"Hemp based products are still relatively new to US
markets and distributors are always looking for innovative lines to sell. Our
Hemp and Cricket pet treats on shelves in the US, even without CBD, represents
an opportunity to increase revenues beyond what the Canadian market is capable
of," states Rodney Gelineau, CEO of EastWest Bioscience Inc.
August 2018 figures from New Frontier Data found that
hemp-derived pet supplies generated $13 million in 2017 and by 2022 it's
expected that this number will reach upwards of $125 million.
Currently dogs and cats are the focus of the day as these
are our most common North American pets, however as companies develop better
quality products and increase distribution, we can expect to see horses and
larger animals as beneficiaries of CBD as well, expanding the overall potential
for the market. As more research comes out on the benefits of CBD for animals,
we can look ahead to more companies entering the market, with companies having
early entry in the sector gaining the lead.
For investors
following cannabis stocks, Investor Ideas has created a stock directory of publicly
traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks
About Investorideas.com - News that Inspires
Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news and press releases plus
we create original financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and
videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and
Podcast, Play
by Play sports and stock news column, Investor Ideas
#Potcasts #Cannabis News and Stocks on the Move podcast and
column, Cleantech and Climate Change
Podcast and the AI
Eye Podcast and column covering developments in
AI.
Follow us on Cannabis Social Media
Disclaimer/Disclosure: Investorideas.com is a digital publisher of
third party sourced news, articles and equity research as well as creates
original content, including video, interviews and articles. Original content
created by investorideas is protected by copyright laws other than syndication
rights. Our site does not make recommendations for purchases or sale of stocks,
services or products. Nothing on our sites should be construed as an offer or
solicitation to buy or sell products or securities. All investing involves risk
and possible losses. This site is currently compensated for news publication
and distribution, social media and marketing, content creation and more.
Disclosure is posted for each compensated news release, content published
/created if required but otherwise the news was not compensated for and was
published for the sole interest of our readers and followers. Contact
management and IR of each company directly regarding specific questions. Disclosure: this article featuring Link Reservations Inc. (LVSR) is a paid for service on Investorideas.com –
third party. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global
investors must adhere to regulations of each country. Please read
Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does
not condone the use of cannabis except where permissible by law. Our site does
not possess, distribute, or sell cannabis products.
Contact Investorideas.com
800-665-0411
Get more Marijuana,
hemp & cannabis stock investor ideas-
news, articles, podcasts and stock directories
